Sign in
8-K

Current Report

Summit Therapeutics Inc. Filed Acc 0001193125-26-314214

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d143170d8k.htm…